PUNE, India, February 25, 2016 /PRNewswire/ --
The report "Knock out Mice Model Pricing Analysis, by Indication, Mouse type, End users, Discounting, Corporate Agreements, Economic Model of Demand and Supply, Physiological Characteristics, Business Models, and Stakeholder Analysis", analyzes the factors that impact the pricing of knock-out mice models.
Browse 57 Pages and in-depth TOC on "Knock out Mice Model Pricing Analysis"
Early buyers will receive 10% customization on this report.
Knockout mice model market is expected to be the fastest growing market owing to high investments in the development of new and innovative knockout models. Development of new knockout models also increases the application areas for the models. Knockout mice are produced by inactivating/silencing or "knocking out" an existing gene and replacing it with an artificial piece of DNA, thereby resulting in the loss of gene activity.
Knockout mice models are usually named after the gene that has been inactivated. For instance, the p53 knockout mouse is named after the p53 gene. This gene codes for a protein that arrests cell division and suppresses the growth of tumors, and are hence used in cancer studies. Different research areas that widely use knockout and knock-in mice include studying and modeling different types of cancer, obesity, heart disease, diabetes, arthritis, substance abuse, anxiety, aging, and Parkinson's disease. Apart from widespread use of these mice in diverse research areas, continuous introduction of new models coupled with signing of various licensing agreements that adds to the widened usage of the models is providing impetus for the growth of this market.
The study provides granular information regarding pricing of the knock-out mice models with breakdown into various factors that affect the price of the models. Some of the factors leading to price variations in the knock-out mice models that have been analyzed in the report in detail include indications, type of knock-out mice, agreements, discounts, demand & supply, end-users, and physiological characteristics. For instance, the high popularity and easy availability of mice models for diseases like cancer, diabetes, and cardiovascular diseases translates into relatively lower prices of these models as compared to knockout mice models that address indications such as neurological disorders and rare diseases. Similarly, high complexity in the development of conditional knockouts makes them expensive than constitutive and double knockout models. Moreover, the high demand for some models translates into strong sales, thereby enabling the sellers to reach Break Even Point (BEP) earlier which in turn allows them to recover the cost of development. This factor plays a crucial role in reducing the price of knockout mice models which are in high demand. The report also provides price variations of knock-out mice for the top players in the market. Additionally, it provides insights to both established firms as well as new entrants/smaller firms to gauge the price variation of Knock-out mice models. This pricing assessment of Knock-out mice models would help stakeholders in the market to align or re-align their business strategies with respect to pricing of these models. Appropriate pricing of these models is likely to translate into greater revenue share and customer base for the stakeholders in the market.
Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=95601671
Browse Related Reports:
Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020
Rat Model Market by Type (Outbred, Knockout, Conditioned), Technology (Microinjection, Embryonic Stem Cells), Application (Toxicology, Oncology, CNS), Service (Breeding, Cryopreservation, Quarantine) & Care Products (Cages, Bedding, Feed) - Forecasts to 2020
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets